VEGFA and colorectal cancer: In fact, VEGF levels are positively correlated with the percentage of Tregs, this effect being reversed by VEGF/VEGFR2 blockade in a mouse model of colorectal cancer and by bevacizumab administration in colorectal cancer patients [141,142].